Form 4: Hanover Insurance CEO Granted RSUs for Dividends

Sentiment:

Insider Transaction Report


Hanover Insurance Group's President and CEO, John C. Roche, was granted 132.183 restricted stock units as dividend equivalents under the company's 2022 Long-Term Incentive Plan.

Summary

  • John C. Roche, President and CEO, and a Director of The Hanover Insurance Group, Inc. (THG), reported an acquisition of securities.
  • The transaction involved the grant of 132.183 shares of Common Stock in the form of restricted stock units (RSUs).
  • The grant occurred on 09/26/2025, with a reported acquisition price of $0 per share.
  • These RSUs were granted under the Issuer's 2022 Long-Term Incentive Plan (2022 LTIP) and are associated with the accrual of dividend equivalent rights on previously granted RSUs.
  • The RSUs are scheduled to vest on the third anniversary of the original underlying RSU grant date.
  • Following this transaction, John C. Roche directly beneficially owns 124,686.639 shares of Common Stock.
  • The reported beneficial ownership does not include 14,454 shares held by the Reporting Person's spouse.
  • The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.

Sentiment

Score: 7

Explanation: The filing reports a routine executive compensation event (grant of RSUs for dividend equivalents) which is generally positive for aligning management incentives with shareholder interests, but does not represent new material financial performance.

Positives

  • The grant of restricted stock units (RSUs) aligns executive interests with shareholder returns by providing equity-based compensation.
  • The transaction is part of a pre-arranged Rule 10b5-1 plan, indicating a structured approach to executive compensation and insider trading compliance.

Future Outlook

The granted restricted stock units are scheduled to vest on the third anniversary of the date of grant of the original underlying RSUs, indicating a future vesting event tied to long-term performance and retention.

Management Comments

  • The transaction reflects the company's ongoing executive compensation strategy under the 2022 Long-Term Incentive Plan.

Industry Context

The grant of restricted stock units as dividend equivalents is a common practice in executive compensation across the insurance industry and broader corporate landscape. It serves to incentivize long-term performance and align management's interests with those of shareholders by linking compensation to equity value and dividend accrual.

Comparison to Industry Standards

  • The use of Restricted Stock Units (RSUs) as a component of executive compensation, particularly for dividend equivalents, is a widely adopted practice across the S&P 500 and within the insurance sector, comparable to compensation structures at companies like Travelers (TRV) or Chubb (CB).
  • The vesting schedule, typically over several years, is standard for long-term incentive plans, aiming to retain executives and encourage sustained performance, similar to programs observed at peer companies.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Executive Compensation PlanGrant of restricted stock units under the Issuer's 2022 Long-Term Incentive Plan (2022 LTIP).09/26/2025Reinforces long-term incentive structure for executive management, aligning their interests with shareholder value creation.
Insider Trading ComplianceTransaction made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).09/26/2025Demonstrates adherence to SEC regulations regarding insider trading, providing a pre-arranged framework for executive stock transactions.

Related Party Transactions

  • The grant of restricted stock units to John C. Roche, the President and CEO, is a transaction between the company and a related party (executive management).

Stakeholder Impact

  • Shareholders: The RSU grant, tied to dividend equivalents, aims to align executive incentives with shareholder returns and long-term company performance.
  • Employees: No direct impact on the broader employee base is indicated by this specific filing.

Next Steps

  • Vesting of the granted restricted stock units on the third anniversary of the original underlying RSU grant date.

Key Dates

DateDescription
09/26/2025Date of transaction for the grant of restricted stock units.
09/30/2025Date the Form 4 was signed by Lindsay L. Katz on behalf of John C. Roche.

Recommendation

hold

This Form 4 reports a routine grant of restricted stock units to the CEO as part of an existing long-term incentive plan. It does not introduce new material information that would significantly alter the investment thesis for Hanover Insurance Group, thus a 'hold' recommendation is appropriate.

Keywords

THG, Hanover Insurance Group, John C. Roche, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Form 4, Long-Term Incentive Plan, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.